(TLTW) iShares Trust - iShares - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • • Long Government
TLTW: Treasury Bonds, Call Options
The iShares Trust - iShares 20+ Year Treasury Bond BuyWrite Strategy ETF, listed on BATS under the ticker TLTW, is designed to implement a buy-write strategy. This involves the fund purchasing shares of an underlying fund, in this case, focused on 20+ year Treasury bonds, and then writing call options on those shares. The key characteristic of this strategy is that the fund will only write call options up to the full amount of the shares it holds in the underlying fund, ensuring that the short position in the call option is completely covered by the long position in the shares. This approach is known as a covered call strategy, which can help generate additional income from the premiums received from selling the call options, potentially enhancing the overall return of the fund.
As an ETF categorized under Long Government, the iShares 20+ Year Treasury Bond BuyWrite Strategy ETF is primarily invested in long-term government securities, specifically Treasury bonds with maturities of 20 years or more. This focus on long-term Treasury bonds means the fund is exposed to the performance of the long-end of the yield curve, which can be sensitive to changes in interest rates and inflation expectations. The buy-write strategy overlay adds a layer of complexity, as the fund's returns will not only be influenced by the price movements of the underlying Treasury bonds but also by the premiums earned from the call options and the impact of volatility on option pricing.
The use of a buy-write strategy in the context of a long government bond ETF like TLTW can offer investors a unique combination of potential income generation and exposure to the long-term Treasury market. By writing call options on a portion of its holdings, the fund can potentially increase its income distribution to shareholders, which can be attractive in a low-yield environment. However, this strategy also means that the fund may cap its potential upside if the prices of the underlying Treasury bonds were to rise significantly, as the call options written could limit the fund's ability to fully participate in such gains.
Additional Sources for TLTW ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TLTW ETF Overview
Market Cap in USD | 971m |
Category | Long Government |
TER | 0.35% |
IPO / Inception | 2022-08-18 |
TLTW ETF Ratings
Growth 5y | -31.6% |
Fundamental | - |
Dividend | 66.9% |
Rel. Strength Industry | 140 |
Analysts | - |
Fair Price Momentum | 24.60 USD |
Fair Price DCF | - |
TLTW Dividends
Dividend Yield 12m | 14.48% |
Yield on Cost 5y | 12.68% |
Annual Growth 5y | 6.41% |
Payout Consistency | 90.0% |
TLTW Growth Ratios
Growth Correlation 3m | -59.2% |
Growth Correlation 12m | 53.2% |
Growth Correlation 5y | -43.6% |
CAGR 5y | -5.12% |
CAGR/Mean DD 5y | -0.54 |
Sharpe Ratio 12m | -0.23 |
Alpha | -9.52 |
Beta | 0.29 |
Volatility | 9.32% |
Current Volume | 758.8k |
Average Volume 20d | 1006.7k |
As of January 22, 2025, the stock is trading at USD 23.64 with a total of 758,846 shares traded.
Over the past week, the price has changed by +2.69%, over one month by +0.60%, over three months by -2.28% and over the past year by +1.28%.
Probably not. Based on ValueRay Analyses, iShares Trust - iShares (BATS:TLTW) is currently (January 2025) not a good stock to buy. It has a ValueRay Growth Rating of -31.64 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TLTW as of January 2025 is 24.60. This means that TLTW is currently overvalued and has a potential downside of 4.06%.
iShares Trust - iShares has no consensus analysts rating.
According to ValueRays Forecast Model, TLTW iShares Trust - iShares will be worth about 26.7 in January 2026. The stock is currently trading at 23.64. This means that the stock has a potential upside of +13.03%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 26.7 | 13% |